CN205538690U - Cancer urine detection kit - Google Patents
Cancer urine detection kit Download PDFInfo
- Publication number
- CN205538690U CN205538690U CN201521029168.1U CN201521029168U CN205538690U CN 205538690 U CN205538690 U CN 205538690U CN 201521029168 U CN201521029168 U CN 201521029168U CN 205538690 U CN205538690 U CN 205538690U
- Authority
- CN
- China
- Prior art keywords
- cancer
- urine detection
- test kit
- detection test
- liner
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 66
- 201000011510 cancer Diseases 0.000 title claims abstract description 66
- 210000002700 urine Anatomy 0.000 title claims abstract description 44
- 238000001514 detection method Methods 0.000 title claims abstract description 43
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 24
- 238000012360 testing method Methods 0.000 claims description 31
- MCAHWIHFGHIESP-UHFFFAOYSA-N selenous acid Chemical compound O[Se](O)=O MCAHWIHFGHIESP-UHFFFAOYSA-N 0.000 abstract description 11
- 239000007864 aqueous solution Substances 0.000 abstract description 7
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 238000013399 early diagnosis Methods 0.000 abstract description 2
- 239000000834 fixative Substances 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000011017 operating method Methods 0.000 description 6
- 239000000376 reactant Substances 0.000 description 6
- 101150038956 cup-4 gene Proteins 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004737 colorimetric analysis Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- -1 Sulphur compound Chemical class 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The utility model discloses a cancer urine detection kit, it includes a box body, a liner, a reagent bottle and a plurality of reaction cup that is equipped with detect reagent, wherein, the liner setting is equipped with a hole and a plurality of hole that is used for the fixation reaction cup that is used for the fixative agent bottle on the liner in the box body, detect reagent is the selenous acid aqueous solution that concentrated hydrochloric acid or concentration are 20~30wt%. The utility model discloses a cancer urine detection kit simple structure, convenient to use can realize that the early diagnosis has of great significance to the cancer to the splendid attire of the detect reagent concentrated hydrochloric acid or the selenous acid aqueous solution and with the function of diagnosing the cancer after detect reagent and the urine reaction fast, and detect swift, nos wound, do not have painful, easy operation, the sensitivity height, the specificity is strong, the reliability is up to 80~90%.
Description
Technical field
This utility model relates to a kind of cancer urine detection test kit.
Background technology
Cancer is one of the commonly encountered diseases of serious harm people's health, frequently-occurring disease, and data shows according to statistics,
China there are about more than 200 ten thousand people every year and died from cancer in recent years.The harm of cancer maximum is that cancer is in early days
Stage patient is almost without any manifest symptom, and when patient has subjective symptoms to go to see a doctor, and cancer
In often having had evolved to, late period, miss the good chance for the treatment of.
According to current medical level, cancer patient finds symptom in early days, and connects and subject there are about 90%
More than can cure, but find symptom at middle and advanced stage, accept after treatment can more than 5-year Survival the most no
To 10%.Therefore, discovery morning of cancer is particularly important for treatment cancer.
Cancer urine detection reagent is owing to just can fast and effeciently detect symptom in early days in cancer, it is to avoid
Cancer patient misses early treatment's good opportunity, thus by the extensive concern of medical circle.But, current cancer
Disease urine detection reagent is primarily directed to the detection of hydroxy phenylalanine in urine, is not directed in urine contain
Sulphur compound and the detection of toxohormone metabolite.And some presently commercially available test kits are either at knot
The most all can not meet on structure or in use and be produced by sulfur-containing compound and toxohormone metabolism in detection urine
Thing diagnoses the requirement of cancer.
Utility model content
This utility model is solved the technical problem that to be to fill up to there is no one at present in detection urine
Sulfur-containing compound and toxohormone metabolite diagnose the blank of the test kit of cancer, it is provided that a kind of cancer
Urine detection test kit.Cancer urine detection reagent cartridge configuration of the present utility model is simple, with low cost,
Easy to use, it is possible to realize for detectable concentrated hydrochloric acid or the splendid attire of Monohydrated selenium dioxide aqueous solution and will detect
Reagent react with urine after the function of quick diagnosis cancer.
This utility model solves above-mentioned technical problem by following technical proposals:
A kind of cancer urine detection test kit, it include a box body, a liner, one equipped with detectable
Reagent bottle and some reaction cup, described liner is arranged in box body, and described liner is provided with one for fixing
The hole of reagent bottle and some holes for fixing reaction cup；Described detectable is concentrated hydrochloric acid or concentration is
The Monohydrated selenium dioxide aqueous solution of 20～30wt%.
Wherein, described concentrated hydrochloric acid is concentrated hydrochloric acid commonly used in the art, and concentration is generally 36～38wt%.
Wherein, described Monohydrated selenium dioxide is Monohydrated selenium dioxide commonly used in the art.
Wherein, described reagent bottle is reagent bottle commonly used in the art, generally seals the reagent arranged
Bottle.The volume of described reagent bottle can select according to actual needs, preferably at more than 1mL.
Wherein, described reaction cup is the reaction cup that this area is conventional, and the volume of described reaction cup is preferably
3.5～5mL.
Wherein, the number of described reaction cup can be selected according to the volume of the detectable contained in reagent bottle
Select, select standard as follows: 0.3～0.5mL detectable is equipped with in a reaction cup, such as reagent bottle splendid attire
The volume of detectable be 6mL, optional be equipped with 12～20 reaction cup.For fixing described reaction
The number in the hole of cup is consistent with the number of reaction cup.
Wherein, described reagent bottle and the general removably fixed placement of some reaction cup are in described liner
On hole in.
It is preferred that the described hole for fixating reagent bottle and some holes for fixing reaction cup are respectively provided with
In liner both sides.Described some holes for fixing reaction cup preferably point in a row on described liner or
Multiple rows of arranged in parallel.
It is preferred that described cancer urine detection test kit also includes that a colorimetric card, described colorimetric card are Fructus Pruni pseudocerasi
Red system and blue series colorimetric card, for Determination reagent and the reacted color of urine.
It is preferred that described cancer urine detection test kit also includes a filter element, for filter urine.
It is preferred that described cancer urine detection test kit also includes a operation instructions, described use is said
Bright secretary carries and utilizes detectable concentrated hydrochloric acid or Monohydrated selenium dioxide aqueous assay urine that concentration is 20～30wt%
Diagnosing the operating procedure whether suffering from cancer, described operating procedure includes:
1), take 2mL urina sanguinis and be placed in a reaction cup, then be added dropwise to the detectable of 0.3～0.5mL；
2), vibrating shakes up the most quiet putting about 3 minutes, observes the color of gained reactant liquor, if reactant liquor face
Color presents bright cherry-red or blue, then judge to suffer from most probably cancer.
Wherein, step 1) in, taking urina sanguinis the previous day, patient should cut out various kinds of drug, to get rid of
Medicine and the interference of other illness.
Wherein, step 2) in, can compare with colorimetric card during the color of observing response liquid and judge detection knot
Really；Preferably can also be used with photoelectric colorimetry measure turbidity to judge testing result, described photoelectric colorimetry is
Method commonly used in the art.
Wherein, step 2) in, if judging the most afterwards when patient suffers from cancer most probably, hospital need to be arrived
Do further detailed inspection, make accurately judgement again in conjunction with the clinical symptoms of patient, it is judged that time need to first get rid of
The interference factor of false positive results, such as liver cirrhosis, menstrual phase etc. can be caused, then face in conjunction with other
Bed detection judges, if testing result is the positive, cancer probability is relatively big, if feminine gender then needs into one
Step makees medical observation.
On the basis of meeting common sense in the field, above-mentioned each optimum condition, can combination in any, obtain this reality
By novel each preferred embodiments.
This utility model agents useful for same and raw material are the most commercially.
Positive progressive effect of the present utility model is:
Cancer urine detection reagent cartridge configuration the most of the present utility model is simple, with low cost, easy to use,
It is capable of for detectable concentrated hydrochloric acid or the splendid attire of Monohydrated selenium dioxide aqueous solution and by detectable and urine
The function of quick diagnosis cancer after liquid reaction.
Cancer urine detection test kit the most of the present utility model is significant for early diagnosis of cancer,
Detection is quick, hurtless measure, no pain, simple to operate, highly sensitive, high specificity, and reliability is up to
80～90%, the early stage of the extensive examination and cancer high-risk group that can be used for cancer takes precautions against.
Accompanying drawing explanation
Fig. 1 is the structural representation of this utility model embodiment 1～2 cancer urine detection test kit, wherein
1 be box body, 2 be liner, 3 for reagent bottle, 4 is reaction cup, and 5 is colorimetric card, and 6 is operation instruction
Book.
Detailed description of the invention
This utility model is further illustrated below by the mode of embodiment, but therefore that this practicality is the newest
Type is limited among described scope of embodiments.
Embodiment 1
A kind of cancer urine detection test kit, its structure as it is shown in figure 1, it include box body 1, liner 2,
Equipped with the 3mL reagent bottle 3 of concentrated hydrochloric acid, reaction cup 4, colorimetric card 5 and operation instructions 6.
Wherein, the number of reaction cup is 8, and liner 2 is arranged in box body 1, and liner 2 side is provided with 1
The individual hole for fixating reagent bottle, opposite side is provided with arranged in parallel 8 of point two rows for fixing reaction cup
Hole, reagent bottle 3 and 8 reaction cup 4 removably fixed placement are in hole；Operation instructions
Recording and utilize concentrated hydrochloric acid detection urine to diagnose the operating procedure whether suffering from cancer, this operating procedure includes:
1), take 2mL urina sanguinis and be placed in a reaction cup, then be added dropwise to the concentrated hydrochloric acid of 0.3～0.5mL；
2), vibrating shakes up the most quiet putting about 3 minutes, observes the color of gained reactant liquor, if reactant liquor face
Color presents bright cherry-red or blue, then judge to suffer from most probably cancer；
Wherein, step 1) in, taking urina sanguinis the previous day, patient should cut out various kinds of drug, to get rid of
Medicine and the interference of other illness；
Step 2) in, compare with colorimetric card during the color of observing response liquid and judge testing result；If sentencing
Determine patient when suffering from cancer most probably, hospital need to be arrived and do further detailed inspection, in conjunction with the clinical condition of patient
Shape makes accurately judgement again, it is judged that time first eliminating need to can cause the interference factor of false positive results, such as liver
Hardening, menstrual phase etc., then judge in conjunction with other Clinical detection, if testing result is the positive,
Cancer probability is relatively big, if feminine gender then needs to make medical observation further.
Embodiment 2
A kind of cancer urine detection test kit, its structure as it is shown in figure 1, it include box body 1, liner 2,
Equipped with the 6mL reagent bottle 3 of the Monohydrated selenium dioxide aqueous solution that concentration is 20～30wt%, reaction cup 4, colorimetric card 5
With operation instructions 6.
Wherein, the number of reaction cup is 15, and liner 2 is arranged in box body 1, and liner 2 side is provided with 1
The individual hole for fixating reagent bottle, opposite side is provided with arranged in parallel 15 of point three rows for fixing reaction
The hole of cup, reagent bottle 3 and 15 reaction cup 4 removably fixed placement are in hole；Use and say
Bright secretary carries the Monohydrated selenium dioxide aqueous assay urine utilizing concentration to be 20～30wt% diagnoses whether suffer from cancer
The operating procedure of disease, this operating procedure includes:
1), take 2mL urina sanguinis and be placed in a reaction cup, then to be added dropwise to 0.3～0.5mL concentration be 20～30wt%
Monohydrated selenium dioxide aqueous solution；
2), vibrating shakes up the most quiet putting about 3 minutes, observes the color of gained reactant liquor, if reactant liquor face
Color presents bright cherry-red or blue, then judge to suffer from most probably cancer；
Wherein, step 1) in, taking urina sanguinis the previous day, patient should cut out various kinds of drug, to get rid of
Medicine and the interference of other illness；
Step 2) in, measure turbidity by photoelectric colorimetry during the color of observing response liquid and judge detection knot
Really；During if it is determined that patient suffers from cancer most probably, hospital need to be arrived and do further detailed inspection, in conjunction with patient
Clinical symptoms make accurately judgement again, it is judged that time first eliminating need to can cause the interference factor of false positive results,
Such as liver cirrhosis, menstrual phase etc., then judge in conjunction with other Clinical detection, if testing result is
The positive then cancer probability is relatively big, if feminine gender then needs to make medical observation further.
Effect example
Cancer urine detection test kit of the present utility model is used to detect hurtless measure, no pain, simple to operate,
Highly sensitive, high specificity, with low cost, the quick diagnosis of cancer can be realized, its reliability is up to
80～90%, the early stage of the extensive examination and cancer high-risk group that can be used for cancer takes precautions against.
Claims (9)
1. a cancer urine detection test kit, it is characterized in that, described cancer urine detection test kit include a box body, a liner, one equipped with the reagent bottle of detectable and some reaction cup, described liner is arranged in box body, and described liner is provided with one for the hole of fixating reagent bottle and some holes for fixing reaction cup；Described detectable is concentrated hydrochloric acid.
2. cancer urine detection test kit as claimed in claim 1, it is characterised in that the volume of described reaction cup is 3.5～5mL.
3. cancer urine detection test kit as claimed in claim 1, it is characterised in that the volume of described reagent bottle is more than 1mL.
4. cancer urine detection test kit as claimed in claim 1, it is characterised in that the described hole for fixating reagent bottle and some holes for fixing reaction cup are separately positioned on liner both sides.
5. cancer urine detection test kit as claimed in claim 1, it is characterised in that described some holes for fixing reaction cup are divided into a row or multi-row arranged in parallel on described liner.
6. cancer urine detection test kit as claimed in claim 1, it is characterised in that in described reagent bottle and some reaction cup removably fixed placement hole on described liner.
7. the cancer urine detection test kit as described in any one of claim 1～6, it is characterised in that described cancer urine detection test kit also includes that a colorimetric card, described colorimetric card are bright cherry-red system and blue series colorimetric card.
8. the cancer urine detection test kit as described in any one of claim 1～6, it is characterised in that described cancer urine detection test kit also includes a filter element.
9. the cancer urine detection test kit as described in any one of claim 1～6, it is characterised in that described cancer urine detection test kit also includes a operation instructions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201521029168.1U CN205538690U (en) | 2015-12-10 | 2015-12-10 | Cancer urine detection kit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201521029168.1U CN205538690U (en) | 2015-12-10 | 2015-12-10 | Cancer urine detection kit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN205538690U true CN205538690U (en) | 2016-08-31 |
Family
ID=56762699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201521029168.1U Expired - Fee Related CN205538690U (en) | 2015-12-10 | 2015-12-10 | Cancer urine detection kit |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN205538690U (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106770265A (en) * | 2017-03-08 | 2017-05-31 | 山东省交通医院 | A kind of kit of quick detection urinary calcium |
| CN107490690A (en) * | 2016-06-13 | 2017-12-19 | 格朗生物技术（上海）有限公司 | A kind of cancer urine early screening is metabolized detection reagent |
| CN109085340A (en) * | 2018-09-29 | 2018-12-25 | 宁波奥丞生物科技有限公司 | A kind of Fluorescence kit applied to reagent detection |
| CN110622006A (en) * | 2017-05-22 | 2019-12-27 | 荣研化学株式会社 | Reagent kit |
-
2015
- 2015-12-10 CN CN201521029168.1U patent/CN205538690U/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107490690A (en) * | 2016-06-13 | 2017-12-19 | 格朗生物技术（上海）有限公司 | A kind of cancer urine early screening is metabolized detection reagent |
| CN106770265A (en) * | 2017-03-08 | 2017-05-31 | 山东省交通医院 | A kind of kit of quick detection urinary calcium |
| CN110622006A (en) * | 2017-05-22 | 2019-12-27 | 荣研化学株式会社 | Reagent kit |
| CN109085340A (en) * | 2018-09-29 | 2018-12-25 | 宁波奥丞生物科技有限公司 | A kind of Fluorescence kit applied to reagent detection |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN205538690U (en) | Cancer urine detection kit | |
| Hartmann et al. | The prognostic significance of subclinical hepatic encephalopathy | |
| Amodio et al. | Improving the inhibitory control task to detect minimal hepatic encephalopathy | |
| Chapple et al. | Prediction and diagnosis of attachment loss by enhanced chemiluminescent assay of crevicular fluid alkaline phosphatase levels | |
| Black et al. | Racial differences in serum creatine kinase levels | |
| MOLITCH et al. | Spurious serum creatinine elevations in ketoacidosis | |
| ES2539854T3 (en) | Early diagnosis and prediction based on the detection of IL-6 of systemic inflammatory response syndrome and sepsis in asymptomatic patients | |
| Casellas et al. | Applicability of short hydrogen breath test for screening of lactose malabsorption | |
| Doğan et al. | Clinical utility of serum lactate levels for differential diagnosis of generalized tonic–clonic seizures from psychogenic nonepileptic seizures and syncope | |
| CN101025415A (en) | Test paper for detecting uric acid content range in urine | |
| WO2010141719A2 (en) | Materials and methods for measuring nitric oxide levels in a biological fluid | |
| US11717195B2 (en) | Assay and point of care device utilizing saliva for diagnosis and treatment of neurological conditions affecting brain health | |
| Larach et al. | Prediction of Malignant Hyperthermia Susceptibility in Low-risk Subjects An Epidemiologic Investigation of Caffeine Halothane Contracture Responses | |
| Remes-Troche et al. | Diagnostic testing in patients with chronic constipation | |
| Marks | Clinical biochemistry nearer the patient. | |
| Mijinyawa et al. | Prevalence of hypertension among teenage students in Kano, Nigeria | |
| RU2256399C1 (en) | Method for diagnosing latent arterial hypertension | |
| Adibi et al. | Assessment of oral and overall health parameters using the SillHa Oral Wellness System | |
| CN208043670U (en) | A kind of urine detection kit | |
| RU2198402C2 (en) | Method for diagnostics of diabetes mellitus | |
| Horoz et al. | Ambulatory blood pressure monitoring and serum nitric oxide concentration in type 1 diabetic children | |
| JPS6359899A (en) | Method for cancer diagnosis and kit therefor | |
| Phanzu et al. | Insulin resistance-related differences in the relationship between left ventricular hypertrophy and cardiorespiratory fitness in hypertensive Black sub-Saharan Africans | |
| RU2442535C9 (en) | Application of percutaneous gas exchange monitoring for diagnostics of the power shortage states | |
| RU2408256C1 (en) | Method of diagnosing painless myocardial ischemia in women |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20220315 Address after: 363299 No. 30, Wang Ding Nan, sui'an Town, Zhangpu County, Zhangzhou City, Fujian Province Patentee after: Chen Lihong Patentee after: Pu Yuanqing Address before: 200092 room 505, No. 7, Lane 373, Fushun Road, Yangpu District, Shanghai Patentee before: Pu Yuanqing |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160831 |